Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

Charles G. Moertel, Larry K. Kvols, Michael J. O’Connell et al. · Cancer · 1991 · 839 citations · Full text

Medicine, Endocrinology, Oncology +16

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

Francesco Panzuto, S. Nasoni, Massimo Falconi et al. · Endocrine Related Cancer · 2005 · 396 citations · Full text

Medicine, Oncology, Surgery +17

Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables

Giuseppe Pelosi, Enrica Bresaola, Giuseppe Bogina et al. · Human Pathology · 1996 · 269 citations

Medicine, Oncology, Pathology +17

Nonfunctioning Islet Cell Tumors

Raleigh B. Kent, Jonathan A. van Heerden, LOUIS H. WEILAND · Annals of Surgery · 1981 · 259 citations

Medicine, Endocrinology, Oncology +11

Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma

Massimo Falconi, Ursula Plöckinger, Dik J. Kwekkeboom et al. · Neuroendocrinology · 2006 · 258 citations · Full text

Medicine, Endocrinology, Oncology +17